- Home
- ALNY vs TRP Comparison
ALNY vs TRP Comparison
Compare ALNY & TRP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALNY
- TRP
- Stock Information
- Founded
- ALNY 2002
- TRP 1951
- Country
- ALNY United States
- TRP Canada
- Employees
- ALNY N/A
- TRP N/A
- Industry
- ALNY Biotechnology: Pharmaceutical Preparations
- TRP
- Sector
- ALNY Health Care
- TRP
- Exchange
- ALNY Nasdaq
- TRP Nasdaq
- Market Cap
- ALNY 60.7B
- TRP 55.6B
- IPO Year
- ALNY 2004
- TRP N/A
- Fundamental
- Price
- ALNY $452.03
- TRP $54.37
- Analyst Decision
- ALNY Strong Buy
- TRP Buy
- Analyst Count
- ALNY 27
- TRP 2
- Target Price
- ALNY $483.89
- TRP $77.00
- AVG Volume (30 Days)
- ALNY 1.1M
- TRP 2.5M
- Earning Date
- ALNY 10-30-2025
- TRP 11-06-2025
- Dividend Yield
- ALNY N/A
- TRP 4.41%
- EPS Growth
- ALNY N/A
- TRP N/A
- EPS
- ALNY 0.33
- TRP 2.34
- Revenue
- ALNY $3,210,070,000.00
- TRP $10,516,264,743.00
- Revenue This Year
- ALNY $65.55
- TRP $12.04
- Revenue Next Year
- ALNY $41.48
- TRP $5.64
- P/E Ratio
- ALNY $1,376.27
- TRP $23.25
- Revenue Growth
- ALNY 53.24
- TRP 24.53
- 52 Week Low
- ALNY $205.87
- TRP $43.51
- 52 Week High
- ALNY $495.55
- TRP $55.37
- Technical
- Relative Strength Index (RSI)
- ALNY 50.48
- TRP 67.89
- Support Level
- ALNY $417.00
- TRP $49.27
- Resistance Level
- ALNY $459.27
- TRP $51.08
- Average True Range (ATR)
- ALNY 16.59
- TRP 0.91
- MACD
- ALNY -0.57
- TRP 0.53
- Stochastic Oscillator
- ALNY 54.18
- TRP 89.10
About ALNY Alnylam Pharmaceuticals Inc.
Alnylam Pharmaceuticals is a leader in the study of RNA interference (RNAi) therapeutics. RNAi is a naturally occurring biological pathway within cells for sequence-specific silencing and regulation of gene expression. Alnylam has five drugs on the market: Onpattro and Amvuttra for hATTR amyloidosis, Givlaari for acute hepatic porphyria, Oxlumo for primary hyperoxaluria type 1, and Leqvio for hypercholesterolemia. It also has several clinical programs across various therapeutic areas: genetic medicines; cardio-metabolic diseases; hepatic infectious diseases, and CNS/ocular diseases. Upfront fees from research partnerships have boosted Alnylam's cash levels, and the company stands to see additional milestones and royalties from drugs commercialized under collaboration partnerships.
About TRP TC Energy Corporation
TC Energy operates natural gas transmission assets across North America. Segments are determined by country of operation, but both Canadian and US operations are interconnected. Mexican operations are disconnected from the US and only have one customer, the state utility CFE. They also operate power generation assets, with the largest being the Bruce Power nuclear plant.